Skip to main content
HIT
NASDAQ Finance

Health In Tech Reports Q1 Revenue Beat, Reiterates 2026 Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Positive
Importance info
7
Price
$1.57
Mkt Cap
$87.902M
52W Low
$0.555
52W High
$4.02
52W Position info
183% above low
Off High info
61% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

HIT has more than doubled off its 52-week low of $0.555.

Summary

Health In Tech announced its first-quarter 2026 financial results, reporting revenues of $8.8 million, which surpassed analyst expectations, and reiterated its full-year 2026 revenue guidance.


Key Events · Earnings and Guidance · HIT

  • Q1 2026 Revenue Exceeds Expectations

    Health In Tech reported first-quarter 2026 revenue of $8.8 million, a 9.4% increase from $8.0 million in Q1 2025, and notably higher than the $7.35 million expected by analysts.

  • Net Loss and Negative Adjusted EBITDA

    The company reported a net loss of $1.6 million, or $(0.03) per diluted share, in line with analyst expectations, compared to net income of $0.5 million in Q1 2025. Adjusted EBITDA was $(1.3) million, down from $1.2 million in Q1 2025, reflecting higher growth-related expenses.

  • 2026 Revenue Guidance Reiterated

    Health In Tech reiterated its full-year 2026 revenue guidance of $45 million to $50 million, representing 35% to 50% year-over-year growth.

  • Improved Cash Position

    Cash and cash equivalents increased to $10.3 million as of March 31, 2026, up from $7.6 million as of March 31, 2025, partly due to a $7 million PIPE financing completed in March.


Analysis · HIT · Finance

Health In Tech reported first-quarter 2026 financial results, exceeding analyst revenue expectations. While the company posted a net loss and negative Adjusted EBITDA for the quarter, attributed to increased sales and marketing expenses for growth initiatives, it reiterated its full-year 2026 revenue guidance. The revenue beat against expectations could provide a positive signal to investors, despite the decline in profitability compared to the prior year.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HIT was trading at $1.57 on NASDAQ in the Finance sector, with a market capitalization of approximately $87.9M. The 52-week trading range was $0.56 to $4.02. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HIT - Latest Insights

HIT
Nov 13, 2026, 5:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.4017
Real-time Price: $0.380 info
Change: -$0.0217 (-5%) info
Market Cap: $29.939M info
HIT
Nov 13, 2026, 5:08 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4017
Real-time Price: $0.380 info
Change: -$0.0217 (-5%) info
Market Cap: $29.939M info
HIT
Nov 12, 2026, 4:30 PM EST
Source: PR Newswire
Importance Score:
8
Price at Filing: $0.540
Real-time Price: $0.380 info
Change: -$0.160 (-30%) info
Market Cap: $29.939M info
HIT
Nov 12, 2026, 8:09 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.550
Real-time Price: $0.380 info
Change: -$0.170 (-31%) info
Market Cap: $29.939M info
HIT
Nov 06, 2026, 4:34 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.5574
Real-time Price: $0.380 info
Change: -$0.1774 (-32%) info
Market Cap: $29.939M info